Randomized, Open, 2-way Cross Over, Single Dose Study to Evaluate and Compare Safety and Pharmacokinetics of the HCP1004 and VIMOVO 500/20mg in Healthy Korean Male
Phase of Trial: Phase I
Latest Information Update: 31 May 2017
At a glance
- Drugs Esomeprazole/naproxen (Primary)
- Indications Musculoskeletal pain; NSAID-induced gastrointestinal damage; Rheumatoid arthritis
- Focus Pharmacokinetics
- Acronyms ESNP
- Sponsors Hanmi Pharmaceutical
- 18 Mar 2014 Primary endpoint 'Peak-drug-concentration' has been met.
- 18 Mar 2014 Primary endpoint 'Area-under-the-drug-concentration-time-curve' has been met.
- 18 Mar 2014 Results presented at the 115th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History